|
LOC401588 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84945999999186E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.8533999999979E-05 |
| Normal-vs-Stage2 |
2.003900E-04 |
| Normal-vs-Stage3 |
3.51119999997263E-06 |
| Normal-vs-Stage4 |
2.835400E-04 |
| Stage1-vs-Stage2 |
9.656600E-01 |
| Stage1-vs-Stage3 |
2.171400E-01 |
| Stage1-vs-Stage4 |
9.173000E-01 |
| Stage2-vs-Stage3 |
3.818200E-01 |
| Stage2-vs-Stage4 |
9.605800E-01 |
| Stage3-vs-Stage4 |
3.399000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76631999999621E-05 |
| Normal-vs-AfricanAmerican |
5.65179999999499E-05 |
| Normal-vs-Asian |
1.492430E-01 |
| Caucasian-vs-AfricanAmerican |
9.870000E-01 |
| Caucasian-vs-Asian |
2.624000E-01 |
| AfricanAmerican-vs-Asian |
1.542040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54730000001546E-06 |
| Normal-vs-Female |
6.422100E-04 |
| Male-vs-Female |
3.319400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74095999999624E-05 |
| Normal-vs-Age(41-60Yrs) |
7.65919999999864E-05 |
| Normal-vs-Age(61-80Yrs) |
4.9324999999989E-06 |
| Normal-vs-Age(81-100Yrs) |
5.105000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.056400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.289200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.575400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.778400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.821800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.146800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.092200E-01 |
| Normal-vs-Grade 2 |
1.208170E-04 |
| Normal-vs-Grade 3 |
2.41430000003096E-06 |
| Normal-vs-Grade 4 |
1.6682900000009E-05 |
| Grade 1-vs-Grade 2 |
1.144160E-01 |
| Grade 1-vs-Grade 3 |
2.274500E-02 |
| Grade 1-vs-Grade 4 |
3.610100E-02 |
| Grade 2-vs-Grade 3 |
6.425900E-02 |
| Grade 2-vs-Grade 4 |
1.000200E-01 |
| Grade 3-vs-Grade 4 |
7.202200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.995000E-04 |
| Normal-vs-ccB subtype |
7.05459999972291E-07 |
| ccA subtype-vs-ccB subtype |
6.879600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15989999999833E-05 |
| Normal-vs-N1 |
1.77153999999513E-05 |
| N0-vs-N1 |
2.389800E-01 |
|
|
